Rituximab plus epratuzumab effective in follicular lymphoma Healio The combination of rituximab and epratuzumab was associated with comparable response rates and time to progression as rituximab plus chemotherapy in a cohort of patients with previously untreated follicular lymphoma, according to study results. |
